Moleac Pte Ltd
"Moleac is a biopharmaceutical company committed to helping patients and their families reconnect with their lives. We address unmet needs of patients suffering from a loss of brain functions after a brain injury or neurodegenerative diseases. Our focus is to help them regain and maintain independence. We select scientifically proven natural compounds and formulations with origins in traditional medicine, establish their clinical properties, and make them available internationally."
Extra Info
Title: Moleac.com |
URL Source: http://www.moleac.com/
Published Time: Tue, 02 Sep 2025 10:06:45 GMT
Markdown Content:
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
Jul 18 2025 News ### Join Us at AAIC 2025 in Toronto – Booth 1446: Discover Innovations in Alzheimer’s Disease Care Moleac is attending the Alzheimer’s Association International Conference (AAIC) from July 27ᵗʰ to 31ˢᵗ, 2025, in Toronto (Canada). Read More
Jun 30 2025 News ### Advancing Alzheimer’s Care: Highlights from the 2025 Scientific Meeting in Singapore We are delighted to share some key moments from the Scientific Meeting held in Singapore on 28 June 2025. Read More
Jun 27 2025 News ### Highlights from the 2025 Neuro Summit in Bali: Advancing Stroke, TBI, and Alzheimer’s Care Neuro Summit | Bali, Indonesia | 20–22 June 2025. We are excited to share the highlights from the Neuro Summit held in Bali from 20 to 22 June 2025. Read More
Aug 28 2025 News ### Balancing Risk: New Systematic Review Explores VTE Prophylaxis in Intracranial Hemorrhage Patients 📰🧠🔬 INTRACRANIAL HEMORRHAGE STUDY HIGHLIGHTS – Venous thromboembolism prophylaxis in patients with intracranial hemorrhage: a systematic review of considerations... Read More
Aug 12 2025 News ### Moleac at the Forefront of Stroke Recovery at the 10ᵗʰ Ho Chi Minh Stroke Conference Together with our valued Vietnamese partner, EVD Pharma, Moleac was proud to participate in the 10ᵗʰ edition of the Ho Chi Minh Stroke Conference, held from 9 –... Read More
Aug 11 2025 News ### Moleac Joins MCGM 2025 to Support Advancements in Geriatric and Alzheimer’s Care Last week, Moleac proudly joined the 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮𝗻 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗚𝗲𝗿𝗶𝗮𝘁𝗿𝗶𝗰 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 (𝗠𝗖𝗚𝗠) for the very first time, held in beautiful Malacca from August 7–9, alongside our... Read More
Aug 11 2025 News ### 𝗔𝗦𝗡𝗔 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 | 𝗕𝗮𝗹𝗶, 𝗜𝗻𝗱𝗼𝗻𝗲𝘀𝗶𝗮 | 𝟴 – 𝟭𝟬 𝗔𝘂𝗴𝘂𝘀𝘁 𝟮𝟬𝟮𝟱 Together with PT. Ferron Par Pharmaceuticals, Moleac was delighted to participate in the 16ᵗʰ Biennial Convention of the ASEAN Neurological Association (ASNA) 2025,... Read More
Aug 06 2025 News ### Meta-Analysis on NeuroAiD’s Role in Stroke Recovery to Be Featured at ASNA 2025 We are pleased to highlight a featured poster presented by Dr. N. V. Ramani, Chair of the.. Read More
Jul 29 2025 News ### Visit Us at AAIC 2025 in Toronto – Booth #1446: Advancing Alzheimer’s Disease Management Our team is at the Alzheimer’s Association International Conference (AAIC), in Toronto (Canada). Read More
Jul 24 2025 News ### Exercise and Vascular Disease: Key Findings from a Systematic Review on Secondary Prevention and Quality of Life 📰🧠🔬 VASCULAR DISEASE STUDY HIGHLIGHTS – The effects of exercise on secondary prevention and health-related quality of life in people with existing vascular... Read More Jul 18 2025 News ### Join Us at AAIC 2025 in Toronto – Booth 1446: Discover Innovations in Alzheimer’s Disease Care Moleac is attending the Alzheimer’s Association International Conference (AAIC) from July 27ᵗʰ to 31ˢᵗ, 2025, in Toronto (Canada). Read More Jun 30 2025 News ### Advancing Alzheimer’s Care: Highlights from the 2025 Scientific Meeting in Singapore We are delighted to share some key moments from the Scientific Meeting held in Singapore on 28 June 2025. Read More Jun 27 2025 News ### Highlights from the 2025 Neuro Summit in Bali: Advancing Stroke, TBI, and Alzheimer’s Care Neuro Summit | Bali, Indonesia | 20–22 June 2025. We are excited to share the highlights from the Neuro Summit held in Bali from 20 to 22 June 2025. Read More Aug 28 2025 News ### Balancing Risk: New Systematic Review Explores VTE Prophylaxis in Intracranial Hemorrhage Patients 📰🧠🔬 INTRACRANIAL HEMORRHAGE STUDY HIGHLIGHTS – Venous thromboembolism prophylaxis in patients with intracranial hemorrhage: a systematic review of considerations... Read More Aug 12 2025 News ### Moleac at the Forefront of Stroke Recovery at the 10ᵗʰ Ho Chi Minh Stroke Conference Together with our valued Vietnamese partner, EVD Pharma, Moleac was proud to participate in the 10ᵗʰ edition of the Ho Chi Minh Stroke Conference, held from 9 –... Read More Aug 11 2025 News ### Moleac Joins MCGM 2025 to Support Advancements in Geriatric and Alzheimer’s Care Last week, Moleac proudly joined the 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮𝗻 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗚𝗲𝗿𝗶𝗮𝘁𝗿𝗶𝗰 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 (𝗠𝗖𝗚𝗠) for the very first time, held in beautiful Malacca from August 7–9, alongside our... Read More